AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Krystal Biotech, Inc.

$347 +$100.09 (+40.54%)
NASDAQ · 11 Sep 2026 20:00 UTC
Previous Close
$345.55
Day Range
$346.72$354.24
Year Range
$145.46$382.54
Market Cap
10.23B
AVG Volume
370.88K
Trailing/Forward PE
41.96/36.65
PEG ratio
1.76
Dividend Yield
-
Next Earnings Date
2026-11-02
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
0200M400M600M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
KRYS Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
26 Q2440.48M
26 Q1417.3M
25 Q4389.13M
25 Q3373.16M
25 Q2359.2M
25 Q1333.45M
24 Q4290.51M
24 Q3241.52M
24 Q2166.23M
24 Q195.95M
Net Income (USD) · TTM
0100M200M300M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
KRYS Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
26 Q2241.47M
26 Q1225.03M
25 Q4204.83M
25 Q3198.91M
25 Q2146.72M
25 Q1123.96M
24 Q489.16M
24 Q352.37M
24 Q2105.94M
24 Q157.16M
Operating Income (USD) · TTM
-100M0100M200M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
KRYS Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
26 Q2197.92M
26 Q1178.81M
25 Q4161.29M
25 Q3158.24M
25 Q2139.3M
25 Q1108.56M
24 Q465.69M
24 Q327.45M
24 Q2-20.97M
24 Q1-67.59M
EBITDA (USD) · TTM
0100M200M300M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
KRYS EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
26 Q2218.43M
26 Q1200.67M
25 Q4182.73M
25 Q3193.29M
25 Q2180.18M
25 Q1154.94M
24 Q4117.14M
24 Q379.14M
24 Q2124.79M
24 Q169.97M
Cash Flows (USD) · TTM
-100M0100M200M300M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
KRYS Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
26 Q2257.78M
26 Q1237.38M
25 Q4188.91M
25 Q3165.59M
25 Q2185.44M
25 Q1129.32M
24 Q4119.18M
24 Q358.06M
24 Q2-22.76M
24 Q1-54.44M
EPS (USD) · TTM
0246824 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
KRYS EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
26 Q27.98
26 Q17.48
25 Q46.85
25 Q36.67
25 Q24.92
25 Q14.16
24 Q42.99
24 Q31.77
24 Q23.65
24 Q11.87
Expenses (USD) · TTM
0100M200M300MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
KRYS Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
26 Q2233.51M
26 Q1227.05M
25 Q4216.74M
25 Q3202.74M
25 Q2193.54M
25 Q1186.4M
24 Q4171.5M
24 Q3162.36M
24 Q2155.2M
24 Q1151.69M
Shares Outstanding (USD) · TTM
-60M-40M-20M020MBuybacks (Repurchases)Stock-Based Compensation24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
KRYS Shares Outstanding (USD) · TTM by quarter
PeriodShares Outstanding (USD) · TTM
26 Q2-24.46M
26 Q1-24.53M
25 Q4-41.36M
25 Q3-40.95M
25 Q2-54.27M
25 Q1-53.31M
24 Q4-49.13M
24 Q3-45.62M
24 Q2-40.62M
24 Q1-38.8M
Employee Count
0100200300201720182019202020212022202320242025
KRYS Employee Count by quarter
PeriodEmployee Count
2025295
2024275
2023229
2022210
2021119
202075
201951
201837
201712
PE Ratio
255075100125med 39.74Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
KRYS PE Ratio by quarter
PeriodPE Ratio
Sep 2642.43
Sep 2643.81
Aug 2642.98
Aug 2642.38
Aug 2640.63
Aug 2639.92
Jul 2644.4
Jul 2643.63
Jul 2646.19
Jul 2647.61
Jul 2648.82
Jun 2648.45
Jun 2645.3
Jun 2641.38
Jun 2639.18
May 2640.22
May 2638.97
May 2639.86
May 2639.79
May 2637.59
Apr 2638.51
Apr 2638.75
Apr 2636.6
Apr 2636.87
Mar 2634.68
Mar 2635.56
Mar 2634.94
Mar 2635.85
Feb 2638.95
Feb 2636.99
Feb 2640.24
Feb 2639.7
Jan 2640.65
Jan 2640.98
Jan 2641.49
Jan 2638.05
Jan 2635.94
Dec 2536.71
Dec 2535.05
Dec 2535.61
Dec 2534.08
Nov 2531.73
Nov 2530.86
Nov 2530.01
Nov 2528.81
Oct 2538.92
Oct 2536.67
Oct 2537.48
Oct 2535.76
Oct 2536.13
Sep 2533.07
Sep 2532.23
Sep 2528.31
Sep 2529.61
Aug 2529.1
Aug 2529.65
Aug 2529.61
Aug 2527.32
Aug 2536.49
Jul 2534.31
Jul 2534.28
Jul 2534.44
Jul 2533.26
Jun 2532.28
Jun 2530.79
Jun 2531.86
Jun 2531.83
May 2529.28
May 2529.07
May 2530.36
May 2530.73
May 2553.59
Apr 2554.2
Apr 2554.37
Apr 2553.21
Apr 2555.25
Mar 2559.32
Mar 2560.36
Mar 2557.85
Mar 2558.03
Feb 2557.81
Feb 2560.59
Feb 2584.02
Feb 2584.92
Jan 2587.59
Jan 2584.88
Jan 2581.36
Jan 2583.85
Jan 2586.81
Dec 2487.34
Dec 2490.38
Dec 2489.73
Dec 24101.57
Nov 24108.25
Nov 24104.4
Nov 2493.62
Nov 24109.45
Nov 2447.62
Oct 2447.38
Oct 2448.37
Free Cash Flow Yield
-2%0%2%4%6%med 2.48%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
KRYS Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 262.52%
Sep 262.44%
Aug 262.48%
Aug 262.52%
Aug 262.63%
Aug 262.67%
Jul 262.38%
Jul 262.42%
Jul 262.28%
Jul 262.22%
Jul 262.16%
Jun 262.18%
Jun 262.33%
Jun 262.55%
Jun 262.69%
May 262.62%
May 262.71%
May 262.65%
May 262.65%
May 262.45%
Apr 262.4%
Apr 262.38%
Apr 262.52%
Apr 262.5%
Mar 262.66%
Mar 262.59%
Mar 262.64%
Mar 262.57%
Feb 262.37%
Feb 262.49%
Feb 262.07%
Feb 262.1%
Jan 262.05%
Jan 262.03%
Jan 262.01%
Jan 262.19%
Jan 262.32%
Dec 252.27%
Dec 252.38%
Dec 252.34%
Dec 252.44%
Nov 252.62%
Nov 252.7%
Nov 252.77%
Nov 252.89%
Oct 253.25%
Oct 253.45%
Oct 253.37%
Oct 253.53%
Oct 253.5%
Sep 253.82%
Sep 253.92%
Sep 254.46%
Sep 254.27%
Aug 254.34%
Aug 254.26%
Aug 254.27%
Aug 254.63%
Aug 252.86%
Jul 253.04%
Jul 253.04%
Jul 253.03%
Jul 253.14%
Jun 253.23%
Jun 253.39%
Jun 253.27%
Jun 253.28%
May 253.56%
May 253.59%
May 253.44%
May 253.4%
May 252.49%
Apr 252.47%
Apr 252.46%
Apr 252.51%
Apr 252.42%
Mar 252.25%
Mar 252.21%
Mar 252.31%
Mar 252.3%
Feb 252.31%
Feb 252.21%
Feb 251.32%
Feb 251.31%
Jan 251.27%
Jan 251.31%
Jan 251.36%
Jan 251.32%
Jan 251.28%
Dec 241.27%
Dec 241.23%
Dec 241.24%
Dec 241.09%
Nov 241.02%
Nov 241.06%
Nov 241.18%
Nov 241.01%
Nov 24-0.45%
Oct 24-0.45%
Oct 24-0.44%
Price to Sales
10203040med 18.7Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
KRYS Price to Sales by quarter
PeriodPrice to Sales
Sep 2623.26
Sep 2624.02
Aug 2623.56
Aug 2623.23
Aug 2622.27
Aug 2621.88
Jul 2623.94
Jul 2623.52
Jul 2624.91
Jul 2625.67
Jul 2626.32
Jun 2626.13
Jun 2624.43
Jun 2622.32
Jun 2621.13
May 2621.69
May 2621.02
May 2621.5
May 2621.46
May 2619.79
Apr 2620.27
Apr 2620.4
Apr 2619.26
Apr 2619.41
Mar 2618.25
Mar 2618.72
Mar 2618.39
Mar 2618.87
Feb 2620.5
Feb 2619.47
Feb 2621.45
Feb 2621.16
Jan 2621.67
Jan 2621.84
Jan 2622.12
Jan 2620.28
Jan 2619.16
Dec 2519.57
Dec 2518.68
Dec 2518.98
Dec 2518.17
Nov 2516.91
Nov 2516.45
Nov 2516
Nov 2515.36
Oct 2515.9
Oct 2514.98
Oct 2515.31
Oct 2514.61
Oct 2514.76
Sep 2513.51
Sep 2513.16
Sep 2511.56
Sep 2512.09
Aug 2511.89
Aug 2512.11
Aug 2512.09
Aug 2511.16
Aug 2513.57
Jul 2512.76
Jul 2512.75
Jul 2512.8
Jul 2512.36
Jun 2512
Jun 2511.45
Jun 2511.84
Jun 2511.83
May 2510.88
May 2510.81
May 2511.29
May 2511.42
May 2516.45
Apr 2516.63
Apr 2516.69
Apr 2516.33
Apr 2516.96
Mar 2518.2
Mar 2518.52
Mar 2517.75
Mar 2517.81
Feb 2517.74
Feb 2518.59
Feb 2518.22
Feb 2518.41
Jan 2518.99
Jan 2518.41
Jan 2517.64
Jan 2518.18
Jan 2518.83
Dec 2418.94
Dec 2419.6
Dec 2419.46
Dec 2422.03
Nov 2423.47
Nov 2422.64
Nov 2420.3
Nov 2423.73
Nov 2430.35
Oct 2430.19
Oct 2430.83
EV/EBITDA
020406080med 37Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
KRYS EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 2643.08
Sep 2644.6
Aug 2643.68
Aug 2643.02
Aug 2641.09
Aug 2640.3
Jul 2645.73
Jul 2644.86
Jul 2647.73
Jul 2649.33
Jul 2650.68
Jun 2650.27
Jun 2646.74
Jun 2642.35
Jun 2639.87
May 2641.05
May 2639.65
May 2640.65
May 2640.56
May 2637.66
Apr 2638.69
Apr 2638.95
Apr 2636.55
Apr 2636.85
Mar 2634.39
Mar 2635.39
Mar 2634.69
Mar 2635.7
Feb 2639.18
Feb 2636.99
Feb 2637.68
Feb 2637.12
Jan 2638.09
Jan 2638.44
Jan 2638.96
Jan 2635.42
Jan 2633.25
Dec 2534.04
Dec 2532.34
Dec 2532.91
Dec 2531.34
Nov 2528.92
Nov 2528.03
Nov 2527.15
Nov 2525.91
Oct 2527.96
Oct 2526.13
Oct 2526.79
Oct 2525.39
Oct 2525.69
Sep 2523.2
Sep 2522.51
Sep 2519.32
Sep 2520.38
Aug 2519.97
Aug 2520.42
Aug 2520.38
Aug 2518.52
Aug 2525.27
Jul 2523.53
Jul 2523.51
Jul 2523.64
Jul 2522.69
Jun 2521.91
Jun 2520.71
Jun 2521.57
Jun 2521.55
May 2519.51
May 2519.34
May 2520.37
May 2520.66
May 2535.75
Apr 2536.22
Apr 2536.34
Apr 2535.46
Apr 2537.01
Mar 2540.11
Mar 2540.9
Mar 2538.99
Mar 2539.13
Feb 2538.96
Feb 2541.08
Feb 2548.26
Feb 2548.86
Jan 2550.62
Jan 2548.83
Jan 2546.51
Jan 2548.15
Jan 2550.11
Dec 2450.46
Dec 2452.47
Dec 2452.04
Dec 2459.88
Nov 2464.3
Nov 2461.75
Nov 2454.61
Nov 2465.09
Nov 2436
Oct 2435.8
Oct 2436.64
Price/Operating Cashflow
20406080100med 38.34Jan 25May 25Aug 25Nov 25Feb 26Jun 26Sep 26
KRYS Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 2637.62
Sep 2638.84
Aug 2638.11
Aug 2637.58
Aug 2636.03
Aug 2635.4
Jul 2639.92
Jul 2639.22
Jul 2641.53
Jul 2642.81
Jul 2643.89
Jun 2643.56
Jun 2640.73
Jun 2637.21
Jun 2635.22
May 2636.16
May 2635.04
May 2635.84
May 2635.77
May 2638.34
Apr 2639.27
Apr 2639.51
Apr 2637.32
Apr 2637.6
Mar 2635.36
Mar 2636.27
Mar 2635.63
Mar 2636.56
Feb 2639.72
Feb 2637.72
Feb 2645.43
Feb 2644.82
Jan 2645.88
Jan 2646.26
Jan 2646.84
Jan 2642.95
Jan 2640.57
Dec 2541.44
Dec 2539.57
Dec 2540.2
Dec 2538.47
Nov 2535.82
Nov 2534.84
Nov 2533.88
Nov 2532.52
Oct 2529.22
Oct 2527.54
Oct 2528.15
Oct 2526.85
Oct 2527.13
Sep 2524.83
Sep 2524.2
Sep 2521.26
Sep 2522.23
Aug 2521.85
Aug 2522.27
Aug 2522.23
Aug 2520.52
Aug 2532.66
Jul 2530.71
Jul 2530.69
Jul 2530.83
Jul 2529.77
Jun 2528.89
Jun 2527.56
Jun 2528.52
Jun 2528.49
May 2526.21
May 2526.02
May 2527.17
May 2527.5
May 2538.71
Apr 2539.16
Apr 2539.27
Apr 2538.44
Apr 2539.91
Mar 2542.85
Mar 2543.6
Mar 2541.79
Mar 2541.92
Feb 2541.76
Feb 2543.77
Feb 2569.47
Feb 2570.21
Jan 2572.41
Jan 2570.18
Jan 2567.27
Jan 2569.32
Jan 2571.78
Dec 2472.21
Dec 2474.72
Dec 2474.18
Dec 2483.98
Nov 2489.5
Nov 2486.31
Nov 2477.4
Nov 2490.49
Price to Book
246810med 5.64Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
KRYS Price to Book by quarter
PeriodPrice to Book
Sep 267.54
Sep 267.78
Aug 267.64
Aug 267.53
Aug 267.22
Aug 267.09
Jul 267.83
Jul 267.69
Jul 268.14
Jul 268.39
Jul 268.6
Jun 268.54
Jun 267.98
Jun 267.29
Jun 266.9
May 267.09
May 266.87
May 267.03
May 267.01
May 266.31
Apr 266.47
Apr 266.51
Apr 266.15
Apr 266.19
Mar 265.82
Mar 265.97
Mar 265.87
Mar 266.02
Feb 266.54
Feb 266.21
Feb 267.03
Feb 266.94
Jan 267.11
Jan 267.16
Jan 267.25
Jan 266.65
Jan 266.28
Dec 256.42
Dec 256.13
Dec 256.23
Dec 255.96
Nov 255.55
Nov 255.39
Nov 255.25
Nov 255.04
Oct 255.49
Oct 255.17
Oct 255.28
Oct 255.04
Oct 255.09
Sep 254.66
Sep 254.54
Sep 253.99
Sep 254.17
Aug 254.1
Aug 254.18
Aug 254.17
Aug 253.85
Aug 254.59
Jul 254.32
Jul 254.32
Jul 254.34
Jul 254.19
Jun 254.06
Jun 253.88
Jun 254.01
Jun 254.01
May 253.69
May 253.66
May 253.82
May 253.87
May 255.05
Apr 255.11
Apr 255.12
Apr 255.01
Apr 255.2
Mar 255.59
Mar 255.69
Mar 255.45
Mar 255.47
Feb 255.45
Feb 255.71
Feb 254.97
Feb 255.02
Jan 255.18
Jan 255.02
Jan 254.81
Jan 254.96
Jan 255.13
Dec 245.16
Dec 245.34
Dec 245.3
Dec 246.01
Nov 246.4
Nov 246.17
Nov 245.53
Nov 246.47
Nov 246.01
Oct 245.98
Oct 246.11
Krystal Biotech, Inc.
KRYS
Stockpicker

Video analysis: KRYS

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: KRYS

Hsbc Holdings PLC Invests $3.65 Million in Krystal Biotech, Inc. $KRYS

defenseworld.net · 11 Sep 2026

Hsbc Holdings PLC Invests $3.65 Million in Krystal Biotech, Inc. $KRYS

Hsbc Holdings PLC purchased a new stake in Krystal Biotech, Inc. (NASDAQ: KRYS) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 9,598 shares of the company's stock, valued at approximately $3,653,000. Other hedge funds also recently modified their holdings of the

Krystal Stock Gains 13.4% in a Month: What Is Driving the Rally?

zacks.com · 3 Sep 2026

Krystal Stock Gains 13.4% in a Month: What Is Driving the Rally?

KRYS' Vyjuvek growth and expanding genetic medicine pipeline boost investor confidence as the company advances toward multi-product growth.

Krystal Biotech to Present at 2026 Cantor Global Healthcare Conference

globenewswire.com · 3 Sep 2026

Krystal Biotech to Present at 2026 Cantor Global Healthcare Conference

PITTSBURGH, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) today announced that the Company will participate in the 2026 Cantor Global Healthcare Conference on September 10, 2026, in New York. Management will take part in a fireside chat scheduled at 3:55 pm ET and host investor meetings throughout the day.

Krystal Biotech (KRYS) Up 12% Since Last Earnings Report: Can It Continue?

zacks.com · 2 Sep 2026

Krystal Biotech (KRYS) Up 12% Since Last Earnings Report: Can It Continue?

Krystal Biotech (KRYS) reported earnings 30 days ago. What's next for the stock?

Here Are Friday’s Top Wall Street Analyst Research Calls: Cinemark, Digital Realty, Fox Corporation, Krystal Biotech, LTC Properties, Roku, Sandisk, T-Mobile US, Wayfair, and More

247wallst.com · 14 Aug 2026

Here Are Friday’s Top Wall Street Analyst Research Calls: Cinemark, Digital Realty, Fox Corporation, Krystal Biotech, LTC Properties, Roku, Sandisk, T-Mobile US, Wayfair, and More

Wall Street flipped the script Friday with a wave of surprise upgrades and downgrades hitting names like Wayfair, Roku, and Fox Corporation, while cooler inflation data reshuffled bets across stocks, bonds, oil, and crypto all at once.

Krystal Q2 Earnings & Sales Beat Estimates, Pipeline in Focus

zacks.com · 4 Aug 2026

Krystal Q2 Earnings & Sales Beat Estimates, Pipeline in Focus

KRYS tops Q2 EPS estimates as Vyjuvek sales climb 24%, but its shares fall despite broader access, global expansion and pipeline progress.

Krystal Biotech, Inc. (KRYS) Q2 2026 Earnings Call Transcript

seekingalpha.com · 3 Aug 2026

Krystal Biotech, Inc. (KRYS) Q2 2026 Earnings Call Transcript

Krystal Biotech, Inc. (KRYS) Q2 2026 Earnings Call Transcript

Krystal Biotech Q2 Earnings Call Highlights

marketbeat.com · 3 Aug 2026

Krystal Biotech Q2 Earnings Call Highlights

Krystal Biotech NASDAQ: KRYS reported second-quarter 2026 net revenue of $119.2 million from global sales of VYJUVEK, up 24% from $96 million in the prior-year period, as the company expanded treatment access for patients with dystrophic epidermolysis bullosa, or DEB, in the United States and overseas.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.